Form 8-K - Current report:
SEC Accession No. 0001193125-26-253709
Filing Date
2026-06-02
Accepted
2026-06-02 16:45:51
Documents
11
Period of Report
2026-05-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d139032d8k.htm   iXBRL 8-K 36853
  Complete submission text file 0001193125-26-253709.txt   151348

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cue-20260529.xsd EX-101.SCH 3189
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20260529_lab.xml EX-101.LAB 17233
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20260529_pre.xml EX-101.PRE 10819
15 EXTRACTED XBRL INSTANCE DOCUMENT d139032d8k_htm.xml XML 3525
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 261056983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)